Tower Research Capital (TRC)’s Achaogen Inc AKAO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-2,361
| Closed | -$1K | – | 4719 |
|
|
2019
Q1 | $1K | Buy |
2,361
+30
| +1% | +$31 | ﹤0.01% | 3705 |
|
|
2018
Q4 | $3K | Buy |
2,331
+585
| +34% | +$1.56K | ﹤0.01% | 3285 |
|
|
2018
Q3 | $7K | Buy |
+1,746
| New | +$10.6K | ﹤0.01% | 3003 |
|
|
2018
Q2 | – | Sell |
-754
| Closed | -$10K | – | 4351 |
|
|
2018
Q1 | $10K | Sell |
754
-17,894
| -96% | -$203K | ﹤0.01% | 2483 |
|
|
2017
Q4 | $201K | Buy |
18,648
+14,725
| +375% | +$185K | 0.03% | 554 |
|
|
2017
Q3 | $62K | Buy |
3,923
+3,039
| +344% | +$57.8K | 0.01% | 1785 |
|
|
2017
Q2 | $19K | Buy |
+884
| New | +$20.2K | ﹤0.01% | 1258 |
|
|
2017
Q1 | – | Sell |
-20
| Closed | – | – | 4368 |
|
|
2016
Q4 | $0 | Sell |
20
-1,916
| -99% | -$13.1K | ﹤0.01% | 4738 |
|
|
2016
Q3 | $9K | Buy |
1,936
+1,055
| +120% | +$4.21K | ﹤0.01% | 2176 |
|
|
2016
Q2 | $3K | Buy |
881
+31
| +4% | +$108 | ﹤0.01% | 3797 |
|
|
2016
Q1 | $2K | Sell |
850
-1,824
| -68% | -$7.09K | ﹤0.01% | 3531 |
|
|
2015
Q4 | $15K | Sell |
2,674
-3,959
| -60% | -$22.7K | ﹤0.01% | 1645 |
|
|
2015
Q3 | $38K | Buy |
6,633
+4,931
| +290% | +$33.6K | ﹤0.01% | 1227 |
|
|
2015
Q2 | $10K | Buy |
1,702
+159
| +10% | +$986 | ﹤0.01% | 2741 |
|
|
2015
Q1 | $15K | Buy |
1,543
+38
| +3% | +$428 | ﹤0.01% | 2497 |
|
|
2014
Q4 | $20K | Buy |
+1,505
| New | +$15.3K | ﹤0.01% | 1611 |
|
|
2014
Q3 | – | Sell |
-5,340
| Closed | -$75K | – | 5133 |
|
|
2014
Q2 | $75K | Buy |
5,340
+4,945
| +1,252% | +$69.3K | 0.01% | 1055 |
|
|
2014
Q1 | $6K | Buy |
+395
| New | +$6.83K | ﹤0.01% | 3161 |
|
Other funds holding AKAO
NMC
GF
GI
SM
Tower Research Capital (TRC)'s AKAO Position: Q2 2019 in Review
Tower Research Capital (TRC) sold out of Achaogen Inc (AKAO) in Q2 2019, closing a stake of 2,361 shares — an estimated $1K sold.
Tower Research Capital (TRC) first reported a position in AKAO in Q1 2014 and held it in 18 quarters. The position peaked at $201K in Q4 2017. 8 funds tracked by Wall St. Rank hold AKAO as of Q2 2019.
- Tower Research Capital (TRC) reported no remaining Achaogen Inc position as of Q2 2019 after selling out during the quarter.
- Tower Research Capital (TRC) sold 2,361 Achaogen Inc shares in Q2 2019, an estimated $1K.
- Tower Research Capital (TRC) first reported a position in Achaogen Inc in Q1 2014 and held it in 18 quarters.
- Tower Research Capital (TRC)'s Achaogen Inc position peaked at $201K in Q4 2017.
- 8 funds tracked by Wall St. Rank held Achaogen Inc as of Q2 2019.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.